3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
11
Neoplasms
8
Head and Neck Neoplasms
8
Ovarian Neoplasms
6
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Sarcoma
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Hematologic Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Psychological Well-Being
2
Motor Activity
2
Melanoma
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Communication
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Cyclophosphamide
26
fludarabine
18
Dexamethasone
17
pembrolizumab
12
Rituximab
11
Etoposide
10
venetoclax
9
pomalidomide
9
Gemcitabine
9
fludarabine phosphate
7
daratumumab
7
Lenalidomide
7
Bortezomib
7
carfilzomib
6
obinutuzumab
5
glofitamab
5
Vincristine
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Doxorubicin
4
Cytarabine
4
Carboplatin
4
zanubrutinib
3
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Surveys and Questionnaires
×
90 days
×
Clear all
No trials found.